Table 6.
Association of Adiposity Measures with Type 2 Diabetes in Nonobese African-Caribbean Men (N = 531, Body Mass Index <30 kg/m2)
| Adjustment model | BMI, SD = 4.7 kg/m2 | VAT, SD = 57 cm3 | PAT, SD = 23 cm3 | Liver attenuation*, SD = 8.1 HU | Muscle attenuation*, SD = 4.2 mg/cm3 |
|---|---|---|---|---|---|
| Model 1 (age adjusted) | 2.24 (1.51–3.33) | 1.73 (1.34–2.24) | 1.48 (1.17–1.89) | 1.75 (1.38–2.24) | 1.45 (1.16–1.81) |
| Model 2 (age, lifestyle, health status, and lipid-lowering medication use) | 2.28 (1.50–3.47) | 1.71 (1.30–2.24) | 1.41 (1.10–1.81) | 1.72 (1.33–2.22) | 1.44 (1.15–1.82) |
| Model 2 + BMI | — | 1.36 (0.98–1.89) | 1.12 (0.83–1.51) | 1.55 (1.19–2.03) | 1.29 (1.01–1.65) |
| Model 2 + VAT | — | — | 1.18 (0.85–1.64) | 1.55 (1.17–2.04) | 1.34 (1.06–1.71) |
| Complete mutual adjustment** | 1.62 (0.92–2.86) | 1.25 (0.85–1.84) | 0.92 (0.64–1.31) | 1.42 (1.06–1.91) | 1.28 (1.00–1.65) |
Odds ratios per 1 SD (95% CI) increase or *decrease in adiposity measure.
**
Adjusted for age, lifestyle, health status, lipid-lowering medication use, BMI, VAT, PAT, liver attenuation, and skeletal muscle attenuation.
Bold indicates P < 0.05.
T2D among nonobese men = 20.2%.